Filing excerpt
Caris Assure® is now available for therapeutic response monitoring, and Caris Confirm, our Whole Genome, tumor-informed assay for minimal residual disease, is targeted to launch before year-end.
Source: Autobound Signal API · 74 signals tracked for Caris Life Sciences · updated
Get Caris Life Sciences' live signals in Claude or ChatGPT, or by API
What changed at Caris Life Sciences this week? Use Autobound signals for carislifesciences.com.The company launched Caris Assure Therapy Response Monitoring and enhanced Caris Assure for Therapy selection, with Caris Confirm targeted to launch before year-end.
Filing excerpt
Caris Assure® is now available for therapeutic response monitoring, and Caris Confirm, our Whole Genome, tumor-informed assay for minimal residual disease, is targeted to launch before year-end.
What this signalsFilings often name leadership changes, deals and spending plans.
Technologies
sec-8kproductLaunchGet every 8-K signal for Caris Life Sciences and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Caris Life Sciences this week?”
The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/ac7f2602-3b09-4826-9821-e4dd5306fb29 returns this record as JSON. POST /v1/companies/enrich returns every signal for carislifesciences.com.
{
"signal_id": "ac7f2602-3b09-4826-9821-e4dd5306fb29",
"signal_type": "sec-8k",
"signal_subtype": "productLaunch",
"detected_at": "2026-11-10T07:04:16.613+00:00",
"company": {
"name": "Caris Life Sciences",
"domain": "carislifesciences.com"
},
"data": {
"detail": "The company launched Caris Assure Therapy Response Monitoring and enhanced Caris Assure for Therapy selection, with Caris Confirm targeted to launch before year-end. This ongoing commercial rollout of precision diagnostic assays may create opportunities for clinical trial technology and laboratory automation vendors.",
"metrics": {
"timeframe": "current_quarter"
},
"summary": "Caris Life Sciences launches Caris Assure Therapy Response Monitoring and plans Caris Confirm rollout",
"excerpts": "Caris Assure® is now available for therapeutic response monitoring, and Caris Confirm, our Whole Genome, tumor-informed assay for minimal residual disease, is targeted to launch before year-end.",
"relevance": 0.85,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/2019410/000201941026000067/cai-20261104.htm",
"filing_date": "2026-11-04",
"filing_year": 2026,
"fiscal_year_end": "11/04",
"sales_relevance": "Go-to-market support",
"signal_category": "strategic",
"technologies_mentioned": [
"Whole Genome",
"tumor-informed assay",
"Whole Exome",
"Whole Transcriptome",
"AI-driven digital pathology"
]
}
}
curl https://signals.autobound.ai/v1/signals/ac7f2602-3b09-4826-9821-e4dd5306fb29 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"carislifesciences.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.